| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.42 | 0.007 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |